LON:IMM

ImmuPharma (IMM) Share Price, News & Analysis

ImmuPharma logo
GBX 2.90 +0.49 (+20.37%)
As of 11:58 AM Eastern

About ImmuPharma Stock (LON:IMM)

Advanced

Key Stats

Today's Range
2.54
▼
2.90
50-Day Range
2.56
▼
4.47
52-Week Range
2.40
▼
11
Volume
4.20 million shs
Average Volume
2.52 million shs
Market Capitalization
£18.10 million
P/E Ratio
N/A
Dividend Yield
0.77%
Price Target
N/A
Consensus Rating
N/A

Company Overview

ImmuPharma PLC (LSE AIM: IMM) is a specialty biopharmaceutical company that discovers and develops peptide-based therapeutics. The Company’s portfolio includes novel peptide therapeutics for autoimmune diseases and anti-infectives. The lead program, P140 (Lupuzor™), is a first-in class autophagy immunomodulator for the treatment of Lupus and preclinical analysis suggest therapeutic activity for many other autoimmune diseases that share the same autophagy mechanism of action.

Receive IMM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ImmuPharma and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IMM Stock News Headlines

Worse than socialism
Donald Trump and Bernie Sanders rarely agree on anything, yet both are steering the country toward the same economic system, according to veteran analyst Porter Stansberry. The government has already taken stakes in companies like Intel, Lithium Americas, and MP Materials, while political rhetoric on both sides points toward deeper centralization. Stansberry has spent months investigating what this bipartisan shift could mean for investors navigating the months ahead.tc pixel
ImmuPharma focused on securing P140 licensing deal in 2026
See More Headlines

IMM Stock Analysis - Frequently Asked Questions

ImmuPharma's stock was trading at GBX 6.20 at the beginning of the year. Since then, IMM stock has decreased by 53.3% and is now trading at GBX 2.90.

ImmuPharma plc (LON:IMM) released its earnings results on Tuesday, September, 15th. The company reported GBX (0.84) EPS for the quarter. ImmuPharma had a negative trailing twelve-month return on equity of 559.87% and a net margin of 3,519.56%.

Shares of IMM stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that ImmuPharma investors own include Aminex (AEX), Tesco (TSCO), NIO (NIO), 4D pharma (DDDD), Gulf Keystone Petroleum (GKP), Kodal Minerals (KOD) and Motif Bio (MTFB).

Company Calendar

Last Earnings
9/15/2026
Today
11/20/2026

Industry, Sector and Symbol

Stock Exchange
LON
Industry
Biotechnology
Sub-Industry
Biotechnology
Current Symbol
LON:IMM
CIK
N/A
Fax
N/A
Employees
13
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (0.83)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-£2.51 million
Net Margins
3,519.56%
Pretax Margin
N/A
Return on Equity
-559.87%
Return on Assets
-43.00%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
1.89
Quick Ratio
1.03

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
GBX 0.14 per share
Price / Cash Flow
20.50
Book Value
GBX 0.65 per share
Price / Book
4.49

Miscellaneous

Outstanding Shares
625,286,000
Free Float
N/A
Market Cap
£18.10 million
Optionable
Not Optionable
Beta
3.02
7 Stocks That Could Be Bigger Than Tesla, NVIDIA, and Google Cover

Could the next Tesla, NVIDIA, and Google be hiding in plain sight? Discover seven growth stocks with the potential to become tomorrow's market giants, fueled by breakthroughs in AI, nuclear energy, cybersecurity, and more.

Get This Free Report

This page (LON:IMM) was last updated on 11/20/2026 by MarketBeat.com Staff.
From Our Partners